Clinical Trials Logo

Filter by:
NCT ID: NCT05702697 Completed - Hamstring Tightness Clinical Trials

The Efficacy of Focus Extracorporeal Shock Wave Therapy on Hamstring Tightness

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

To study efficacy of focus extracorporeal shock wave therapy on the flexibility of hamstring muscles in healthy subjects

NCT ID: NCT05702034 Not yet recruiting - Clinical trials for Ischemic Stroke; Ischemic Attack, Transient

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

LIBREXIASTROKE
Start date: February 9, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

NCT ID: NCT05693883 Completed - Allergic Rhinitis Clinical Trials

Pilates Training in Patients With Allergic Rhinitis

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the effects of pilates training on symptoms in patients with allergic rhinitis.

NCT ID: NCT05682937 Enrolling by invitation - Clinical trials for High-Frequency Ventilation

HFOV With Intermittent Sigh Breaths in Neonate: CO2 Level

SighCO2
Start date: January 12, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to the short-term effects of sigh breaths during High-frequency oscillatory ventilation (HFOV) in neonate undergoing mechanical ventilation. From meta-analysis, It revealed HFOV in neonates could reduce chronic lung disease or death rather than conventional ventilation. The main question it aims to answer is: Do sigh breaths augment restoring lung volume and ventilation (CO2 level) in intubated neonate with HFOV? Participants will be applied sigh breaths (HFOV-sigh) during on HFOV. Researchers will compare HFOV-sigh mode to see if CO2 level (before-after intervention).

NCT ID: NCT05682781 Not yet recruiting - Malnutrition Clinical Trials

Nutrition Intervention in Older Adults at Risk of Malnutrition

Start date: February 2023
Phase: N/A
Study type: Interventional

Thailand is one of the fastest aging countries and older adults are at greater risk of having inadequate nutrient intake and malnutrition (undernutrition). In the community setting, malnutrition has been linked to low muscle mass, sarcopenia, increased incidence of disability and functional impairments. The objective of this prospective, multicenter, randomized controlled, open-label, parallel-design study is to determine the effects of an oral nutritional supplement with dietary counseling on body weight, in comparison with dietary counseling alone, in community dwelling older adults at risk of malnutrition.

NCT ID: NCT05664737 Recruiting - Anemia Clinical Trials

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants With Alpha (α)-Thalassemia

Start date: December 9, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine the efficacy and safety of luspatercept plus best supportive care (BSC) vs placebo plus BSC on anemia in participants with α-thalassemia hemoglobin H (HbH) disease.

NCT ID: NCT05660980 Not yet recruiting - HIV-1-infection Clinical Trials

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

Start date: May 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

NCT ID: NCT05650060 Completed - Plaque Psoriasis Clinical Trials

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Start date: January 20, 2021
Phase:
Study type: Observational

This study was a non-interventional, retrospective study collecting data from hospital medical records. Approximately 200 adult patients with moderate to severe plaque psoriasis who were treated with secukinumab from hospitals in Thailand that participated in this study were expected for data collection.

NCT ID: NCT05648448 Not yet recruiting - Influenza Clinical Trials

ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza

AD ASTRA
Start date: January 22, 2023
Phase: Phase 2
Study type: Interventional

This trial will use a previously validated platform, to quantitatively assess antiviral effects in low-risk patients with high viral burdens and uncomplicated influenza, to determine in-vivo antiviral activity. In this randomised, open-label, controlled, group sequential, adaptive, platform trial, we will compare the performance of available influenza antivirals, and those with potential activity, relative to the control (no treatment) and each other. AD ASTRA study is supported by the Wellcome Trust Grant ref: 223195/Z/21/Z through the COVID-19 Therapeutics Accelerator

NCT ID: NCT05641090 Recruiting - Clinical trials for Elderly With Type 2 Diabetes

Effects of Nordic Walking in Water on Cerebrovascular Function and Cognitive Impairment in Elderly With Type 2 Diabetes

Start date: December 16, 2021
Phase: N/A
Study type: Interventional

Nordic walking in water would more advantage than normal daily life in cerebrovascular function and cognitive function in elderly with type 2 diabetes.